Nicole Revencu

Dr. Nicole Revencu


Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 July 2024 in Nature
Verified
Journal Article
Open access
PDF file
YCYuyang Chen
Yuyang Chen
RDRuebena Dawes
Ruebena Dawes
HKHyung Chul Kim
Hyung Chul Kim
ALAlicia Ljungdahl
Alicia Ljungdahl
SSSarah L. Stenton
Sarah L. Stenton
NWNicola Whiffin
Nicola Whiffin
Around 60% of individuals with neurodevelopmental disorders (NDD) remain undiagnosed after comprehensive genetic testing, primarily of protein-coding genes1. Large genome-sequenced cohorts are improving our ability to discover new diagnoses in the non-coding genome. Here we identify the non-coding RNA RNU4-2 as a syndromic NDD gene. RNU4-2 encodes the U4 small nuclear RNA (snRNA), which is a critical component of the U4/U6.U5 tri-snRNP complex of the major spliceosome2. We identify an 18 base pair region of RNU4-2 mapping to two structural elements in the U4/U6 snRNA duplex (the T-loop and stem III) that is severely depleted of variation in the general population, but in which we identify heterozygous variants in 115 individuals with NDD. Most individuals (77.4%) have the same highly recurrent single base insertion (n.64_65insT). In 54 individuals in whom it could be determined, the de novo variants were all on the maternal allele. We demonstrate that RNU4-2 is highly expressed in the developing human brain, in contrast to RNU4-1 and other U4 homologues. Using RNA sequencing, we show how 5′ splice-site use is systematically disrupted in individuals with RNU4-2 variants, consistent with the known role of this region during spliceosome activation. Finally, we estimate that variants in this 18 base pair region explain 0.4% of individuals with NDD. This work underscores the importance of non-coding genes in rare disorders and will provide a diagnosis to thousands of individuals with NDD worldwide.

25 July 2014 in Acta Neuropathologica Communications
Verified
Journal Article
Open access
PDF file
CFCatherine Fallet-Bianco
Catherine Fallet-Bianco
ALAnnie Laquerrière
Annie Laquerrière
KPKarine Poirier
Karine Poirier
FRFerechte Razavi
Ferechte Razavi
FGFabien Guimiot
Fabien Guimiot
NBNadia Bahi-Buisson
Nadia Bahi-Buisson
Complex cortical malformations associated with mutations in tubulin genes are commonly referred to as “Tubulinopathies”. To further characterize the mutation frequency and phenotypes associated with tubulin mutations, we studied a cohort of 60 foetal cases. Twenty-six tubulin mutations were identified, of which TUBA1A mutations were the most prevalent (19 cases), followed by TUBB2B (6 cases) and TUBB3 (one case). Three subtypes clearly emerged. The most frequent (n = 13) was microlissencephaly with corpus callosum agenesis, severely hypoplastic brainstem and cerebellum. The cortical plate was either absent (6/13), with a 2–3 layered pattern (5/13) or less frequently thickened (2/13), often associated with neuroglial overmigration (4/13). All cases had voluminous germinal zones and ganglionic eminences. The second subtype was lissencephaly (n = 7), either classical (4/7) or associated with cerebellar hypoplasia (3/7) with corpus callosum agenesis (6/7). All foetuses with lissencephaly and cerebellar hypoplasia carried distinct TUBA1A mutations, while those with classical lissencephaly harbored recurrent mutations in TUBA1A (3 cases) or TUBB2B (1 case). The third group was polymicrogyria-like cortical dysplasia (n = 6), consisting of asymmetric multifocal or generalized polymicrogyria with inconstant corpus callosum agenesis (4/6) and hypoplastic brainstem and cerebellum (3/6). Polymicrogyria was either unlayered or 4-layered with neuronal heterotopias (5/6) and occasional focal neuroglial overmigration (2/6). Three had TUBA1A mutations and 3 TUBB2B mutations. Foetal TUBA1A tubulinopathies most often consist in microlissencephaly or classical lissencephaly with corpus callosum agenesis, but polymicrogyria may also occur. Conversely, TUBB2B mutations are responsible for either polymicrogyria (4/6) or microlissencephaly (2/6).

5 June 2019 in Genetics in Medicine
Verified
Journal Article
Open access
PDF file
THTzung-Chien Hsieh
Tzung-Chien Hsieh
MMMartin A. Mensah
Martin A. Mensah
JPJean T. Pantel
Jean T. Pantel
DADione Aguilar
Dione Aguilar
OBOmri Bar
Omri Bar
PKPeter M. Krawitz
Peter M. Krawitz
Purpose Phenotype information is crucial for the interpretation of genomic variants. So far it has only been accessible for bioinformatics workflows after encoding into clinical terms by expert dysmorphologists. Methods Here, we introduce an approach driven by artificial intelligence that uses portrait photographs for the interpretation of clinical exome data. We measured the value added by computer-assisted image analysis to the diagnostic yield on a cohort consisting of 679 individuals with 105 different monogenic disorders. For each case in the cohort we compiled frontal photos, clinical features, and the disease-causing variants, and simulated multiple exomes of different ethnic backgrounds. Results The additional use of similarity scores from computer-assisted analysis of frontal photos improved the top 1 accuracy rate by more than 20–89% and the top 10 accuracy rate by more than 5–99% for the disease-causing gene. Conclusion Image analysis by deep-learning algorithms can be used to quantify the phenotypic similarity (PP4 criterion of the American College of Medical Genetics and Genomics guidelines) and to advance the performance of bioinformatics pipelines for exome analysis.

12 July 2019 in Journal of Medical Genetics
Verified
Journal Article
Closed access
PDF file
NRNicole Revencu
Nicole Revencu
EFElodie Fastre
Elodie Fastre
MRMarie Ravoet
Marie Ravoet
RHRaphaël Helaers
Raphaël Helaers
PBPascal Brouillard
Pascal Brouillard
Miikka VikkulaMiikka Vikkula
Miikka Vikkula
Background: Capillary malformation-arteriovenous malformation is an autosomal dominant disorder, characterised by capillary malformations and increased risk of fast-flow vascular malformations, caused by loss-of-function mutations in the RASA1 or EPHB4 genes. Around 25% of the patients do not seem to carry a germline mutation in either one of these two genes. Even if other genes could be involved, some individuals may have mutations in the known genes that escaped detection by less sensitive techniques. We tested the hypothesis that mosaic mutations could explain some of previously negative cases. Methods: DNA was extracted from peripheral blood lymphocytes, saliva or vascular malformation tissues from four patients. RASA1 and EPHB4 coding regions and exon/intron boundaries were analysed by targeted custom gene panel sequencing. A second panel and/or Sanger sequencing were used to confirm the identified mutations. Results: Four distinct mosaic RASA1 mutations, with an allele frequency ranging from 3% to 25%, were identified in four index patients with classical capillary malformation-arteriovenous malformation phenotype. Three mutations were known, one was novel. In one patient, a somatic second hit was also identified. One index case had three affected children, illustrating that the mosaicism was also present in the germline. Conclusion: This study shows that RASA1 mosaic mutations can cause capillary malformation-arteriovenous malformation. Thus, highly sensitive sequencing techniques should be considered as diagnostic tools, especially for patients with no family history. Even low-level mosaicism can cause the classical phenotype and increased risk for offspring. In addition, our study further supports the second-hit pathophysiological mechanism to explain the multifocality of vascular lesions in this disorder.

9 September 2020 in Science Translational Medicine
Verified
Journal Article
Closed access
VLVeli-Matti Leppänen
Veli-Matti Leppänen
PBPascal Brouillard
Pascal Brouillard
EKEmilia A. Korhonen
Emilia A. Korhonen
TSTuomas Sipilä
Tuomas Sipilä
SJSawan Jha
Sawan Jha
KAKari Alitalo
Kari Alitalo
Loss-of-function mutations in the TIE2-ligand angiopoietin 2 are associated with primary lymphedema in humans.

13 July 2022 in European Journal of Neurology
Verified
Journal Article
Closed access
ADAnne Dompmartin
Anne Dompmartin
CVCarine J. M. van der Vleuten
Carine J. M. van der Vleuten
VDValérie Dekeuleneer
Valérie Dekeuleneer
TDThierry Duprez
Thierry Duprez
NRNicole Revencu
Nicole Revencu
LBLaurence Boon
Laurence Boon